Canada markets closed

Inovio Pharmaceuticals, Inc. (GBM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
7.39-0.28 (-3.65%)
At close: 08:05AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
717.067
832.01
10,262
1,775
7,411
-
Operating Expenses
Research Development
77,414
86,677
187,651
249,240
94,245
-
Selling General and Administrative
44,263
47,582
90,185
53,752
37,248
-
Total Operating Expenses
121,677
134,259
277,836
302,993
131,493
-
Operating Income or Loss
-120,959
-133,427
-267,574
-301,218
-124,082
-
Interest Expense
1,087
1,223
1,254
1,936
8,702
-
Total Other Income/Expenses Net
-10,318
-8,601
-13,607
-3,433
-33,418
-
Income Before Tax
-124,938
-135,117
-277,653
-303,224
-162,890
-
Income Tax Expense
-
-
-
0
0
-257.335
Income from Continuing Operations
-124,938
-135,117
-279,818
-303,659
-167,475
-
Net Income
-124,938
-135,117
-279,818
-303,659
-166,411
-
Net Income available to common shareholders
-124,938
-135,117
-279,818
-303,659
-166,411
-
Basic EPS
-7.56
-6.09
-14.07
-17.45
-12.84
-
Diluted EPS
-7.56
-6.09
-14.07
-17.45
-12.84
-
Basic Average Shares
21,711
22,174
19,885
17,402
12,927
-
Diluted Average Shares
21,711
22,174
19,885
17,402
12,927
-